Review: taking Elavil and Savella together


Summary

Drug interactions are reported among people who take Elavil and Savella together. This review analyzes the effectiveness and drug interactions between Elavil and Savella. It is created by eHealthMe based on reports of 141 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Elavil and Savella >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Elavil

Elavil has active ingredients of amitriptyline hydrochloride. It is often used in depression. (latest outcomes from Elavil 11,771 users)

Savella

Savella has active ingredients of milnacipran hydrochloride. It is often used in fibromyalgia. (latest outcomes from Savella 3,324 users)

On Jul, 23, 2016

141 people who take Elavil, Savella are studied.


Number of reports submitted per year:

Elavil and Savella drug interactions.

Drug effectiveness over time:

Elavil:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 50.0% - (2 of 4 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 6 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 66.0% - (4 of 6 people)
  • not specified: 0.0% - (0 of 0 people)
Savella:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 33.0% - (3 of 9 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 83.0% - (5 of 6 people)
  • 2 - 5 years: 0.0% - (0 of 3 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Elavil:
  • female: 26.0% - (5 of 19 people)
  • male: 100.0% - (2 of 2 people)
Savella:
  • female: 47.0% - (8 of 17 people)
  • male: 0.0% - (0 of 3 people)

Drug effectiveness by age:

Elavil:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 16.0% - (1 of 6 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 41.0% - (5 of 12 people)
  • 60+: 0.0% - (0 of 0 people)
Savella:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 71.0% - (5 of 7 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 25.0% - (3 of 12 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • mental status changes
  • dyspnoea
  • nausea
  • decreased appetite
  • blood glucose increased
  • fatigue
  • heart rate increased
  • palpitations
  • anaphylactic shock
  • asthenia
1 - 6 months:
  • activities of daily living impaired
  • feeling abnormal
  • asthenia
  • depression
  • nausea
  • pain
  • palpitations
  • somnolence
  • abdominal discomfort
  • abnormal behaviour
6 - 12 months:
  • mental status changes
  • aggression
  • alexia
  • blood pressure increased
  • confusional state
  • depression aggravated
  • drug ineffective
  • hallucination, visual
  • sweating - excessive
  • weight gain
1 - 2 years:
  • migraine
  • back pain - low
  • facet joint syndrome
  • fibromyalgia
  • gerd
  • myofascial pain syndrome
  • anxiety aggravated
  • cognitive deterioration
  • confusion
  • depression aggravated
2 - 5 years:
  • abdominal bloating
  • abdominal pain
  • back pain - low
  • blood urine
  • constipation aggravated
  • facet joint syndrome
  • fibromyalgia
  • gerd
  • migraine
  • mood swings
10+ years:
  • anxiety aggravated
  • cognitive deterioration
  • confusion
  • depression aggravated
  • discolored teeth
  • dry eyes aggravated
  • eagles syndrome
  • job change
  • memory impairment
  • migraine
not specified:
  • pain
  • nausea
  • dizziness
  • sinusitis
  • psoriasis
  • injection site discolouration
  • skin discolouration
  • migraine
  • chest wall mass
  • dry throat

Most common drug interactions by gender *:

female:
  • injection site discolouration
  • skin discolouration
  • nausea
  • pain
  • migraine
  • mental status changes
  • dizziness
  • sinusitis
  • psoriasis
  • dyspnoea
male:
  • drug abuse
  • serotonin syndrome

Most common drug interactions by age *:

20-29:
  • migraine
  • back pain - low
  • facet joint syndrome
  • fibromyalgia
  • gerd
  • myofascial pain syndrome
  • decreased appetite
  • depression
  • nausea
  • poor quality sleep
30-39:
  • abnormal loss of weight
  • drug ineffective
  • back pain
  • dysuria
  • feeling hot
  • pyrexia
  • urinary tract infection
  • vaginal haemorrhage
  • vulvovaginal pain
  • depression
40-49:
  • pain
  • injection site pain
  • anaphylactic shock
  • dermatitis exfoliative
  • diarrhoea
  • migraine
  • adverse drug reaction
  • fall
  • itching
  • joint pain
50-59:
  • nausea
  • dizziness
  • sinusitis
  • injection site discolouration
  • psoriasis
  • syncope
  • asthenia
  • chest wall mass
  • dry throat
  • herpes simplex
60+:
  • mental status changes
  • confusional state
  • headache
  • nausea
  • pain
  • aggression
  • insomnia
  • drug abuse
  • dyspnoea
  • feeling abnormal

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Elavil and Savella?

Can you answer these questions?

More questions for: Elavil, Savella

You may be interested in these reviews

More reviews for: Elavil, Savella

On eHealthMe, Elavil (amitriptyline hydrochloride) is often used to treat depression. Savella (milnacipran hydrochloride) is often used to treat fibromyalgia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.